– USA, CA – Omada Health, the virtual-first healthcare provider, announced the addition of Dr. Sachin Jain (M.D.), Julie Klapstein, and Dr. Sachin Jain to its Board of Directors.
About Dr. Sachin Jain
Dr. Sachin Jain is a respected and innovative leader in healthcare with a background in both medicine and healthcare management. Dr. Jain currently serves as CEO of SCAN Group and SCAN Health Plan, Professor of Medicine at Stanford, and as a practicing Academic Hospitalist with the U.S. Department of Veterans Affairs. He has had an extensive career, including roles as President and CEO of CareMore Health and Aspire Health; Chief Medical Information & Innovation Officer at Merck & Co.; attending physician at the Boston VA-Boston Medical Center; and faculty member at Harvard Medical and Business Schools. Dr. Jain has also held leadership roles at the U.S. Department of Health and Human Services, where he was Senior Advisor to the Administrator of the Centers for Medicare & Medicaid Services and currently serves on the boards of America’s Health Insurance Plans, Advantage Healthcare Services, and The Paul & Daisy Soros Fellowships for New Americans.
About Julie Klapstein
Julie Klapstein is a seasoned board member, advisor, and entrepreneur. She currently serves as Partner Advisor for a16z and is the founding CEO of Availity, a healthcare IT company working to optimize the automated delivery of critical business and clinical information among healthcare stakeholders. Klapstein has over 30 years of private and corporate experience in the healthcare IT industry, having held executive roles at Phycom, Inc., Sunquest Information Systems, SMS, GTE Health Systems, and AT&T Information Systems, and having served or currently serving on the boards of directors of Amedisys, Alpha II, MultiPlan, NextGen, Oak Street Health, and HCIM.
About Adam Stavisky
Adam Stavisky joins the Omada Board, having most recently served as the SVP of U.S. Benefits for Walmart, where he was responsible for Walmart’s strategic vision and the delivery of all benefits for 1.6 million associates across its U.S. businesses. During his tenure, Stavisky championed system improvements to drive better patient outcomes for Walmart employees. Earlier in his career, Stavisky spent more than 20 years building benefits consulting businesses at several national firms, including Fidelity Investments, Mercer, and Aon Hewitt (formerly Hewitt Associates).
About Omada Health
Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, weight management, and musculoskeletal issues. With more than a decade of experience and data and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.
The foundation of Omada’s success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work. An industry leader, Omada is the first virtual provider to join the Institute for Healthcare Improvement’s Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.
For more information: https://www.omadahealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.